8-K 1 y91976e8vk.txt HALSEY DRUG CO. , INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 19, 2003 HALSEY DRUG CO., INC. 695 NORTH PERRYVILLE ROAD, ROCKFORD, ILLINOIS 61107 (815-399-2060) Incorporated under the laws of Commission File Number I.R.S. Employer Identification Number State of New York 1-10113 11-0853640
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On November 19, 2003, Halsey Drug Co., Inc. (the "Company") issued a press release disclosing the financial results for its third quarter ended September 30, 2003 and the nine months ended September 30, 2003. A copy of the Company's press release is attached as Exhibit 99.1 hereto. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (B) EXHIBITS
EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1 Press Release dated November 19, 2003 Announcing Results for Third Quarter ended September 30, 2003
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. HALSEY DRUG CO., INC. By: /s/ Peter A. Clemens ------------------------------------ Peter A. Clemens Vice President & Chief Financial Officer Date: November 19, 2003 3 EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1 Press Release dated November 19, 2003 Announcing Results for Third Quarter ended September 30, 2003.
4